Search Results - "Anscher, Mitchell Steven"

Five-year results from a phase I/II study of moderately hypofractionated intensity-modulated radiation therapy (IMRT) for localized prostate cancer including simultaneously integrated boost and pelvic lymph node (LN) coverage by Ricco, Anthony, Mukhopadhyay, Nitai, Holdford, Diane, Skinner, Vicki, Saraiya, Siddharth, Moghanaki, Drew, Anscher, Mitchell Steven, Chang, Michael G., Deng, Xiaoyan

“…Abstract only 299 Background: This study reports the 5 year toxicity and efficacy data of a phase I/II trial of moderately hypofractionated intensity modulated…”
Get full text

Impact of Definitive Local Therapy in Men with Primary Small Cell Prostate Carcinoma by Oke, Oluchi, Ranasinghe, Weranja, Tang, Chad, Shaaban, Sherif, Xiao, Lianchun, Reichard, Chad A., Anscher, Mitchell Steven, Chapin, Brian Francis, Aparicio, Ana

Get full text

Impact of definitive local therapy (LT) in men with primary small cell (or poorly differentiated neuroendocrine) prostate carcinomas (pSCPC) by Oke, Oluchi, Tang, Chad, Shaaban, Sherif, Xiao, Lianchun, Reichard, Chad A., Chapin, Brian Francis, Anscher, Mitchell Steven, Aparicio, Ana

“…Abstract only…”
Get full text

Impact of radiotherapy on risk of adverse events in patients receiving immunotherapy: A U.S. Food and Drug Administration pooled analysis by Anscher, Mitchell Steven, Arora, Shaily, Weinstock, Chana, Lubitz, Rachael, Amatya, Anup, Fiero, Mallorie, Tang, Shenghui, Bandaru, Pradeep, Sanchez, Jacquelyn, Girvin, Andrew, Tang, Chad, Amiri-Kordestani, Laleh, Theoret, Marc Robert, Pazdur, Richard, Beaver, Julia A.

“…Abstract only 3018 Background: Immune checkpoint inhibitors (ICIs) are widely used in the treatment of multiple advanced malignancies. Radiotherapy (RT) has…”
Get full text

Metastasis free survival in older men with nonmetastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: An FDA-pooled analysis by Singh, Harpreet, Zhang, Lijun, Amatya, Anup, Gong, Yutao, Suzman, Daniel L., Weinstock, Chana, Chang, Elaine, Anscher, Mitchell Steven, Chi, Dow-Chung, Xu, James, Brewer, Jamie Renee, Agrawal, Sundeep, Brave, Michael Holman, Hadadi, Mehrnoosh, Theoret, Marc Robert, Kluetz, Paul Gustav, Ibrahim, Amna, Pazdur, Richard, Beaver, Julia A.

“…Abstract only 12038 Background: The FDA has approved three androgen receptor (AR) inhibitors for nonmetastatic castration-resistant prostate cancer (nmCRPC)…”
Get full text

Influence of palliative care consult on radiation therapy utilization for metastatic cancer patients within the last six months by Schuster, Jessica Moore, Tam, Karman, Skoro, Nevena, Cassel, Brian, Anscher, Mitchell Steven, Moghanaki, Drew

“…Abstract only 149 Background: Palliative care encounters (PCE) have been demonstrated to reduce resource utilization and costs within an inpatient setting…”
Get full text

Phase II study of lovastatin to prevent rectal injury from radiation therapy for prostate cancer by Anscher, Mitchell Steven, Chang, Michael G., Moghanaki, Drew, Rosu, Mihaela, Mikkelsen, Ross, Holdford, Diane, Skinner, Vicki, Grob, B Mayer, Sanyal, Arun J., Mukhopadhyay, Nitai

“…Abstract only 120 Background: Late radiation induced rectal injury remains an issue. Large population based studies indicate an incidence of at least 15%…”
Get full text

Availability of single-fraction palliative radiotherapy for cancer patients receiving end-of-life care within the Veterans Healthcare Administration by Moghanaki, Drew, Cheuk, Alice V., Fosmire, Helen, Anscher, Mitchell Steven, Hagan, Michael Philip, Lutz, Stephen T., Dawson, George A.

“…Abstract only…”
Get full text

Prostate cancer specific mortality and overall survival outcomes for salvage radiation therapy after radical prostatectomy by Agrawal, Shree, Efstathiou, Jason A., Michalski, Jeff M., Pisansky, Thomas Michael, Koontz, Bridget F., Liauw, Stanley L., Abramowitz, Matthew, Pollack, Alan, Anscher, Mitchell Steven, Moghanaki, Drew, Den, Robert B., Zietman, Anthony L., Lee, W. Robert, Stephans, Kevin L., Hearn, Jason W.D., Spratt, Daniel Eidelberg, Gao, Tianming, Kattan, Michael W., Stephenson, Andrew J., Tendulkar, Rahul D.

“…Abstract only…”
Get full text

Prostate cancer specific mortality and overall survival outcomes for salvage radiation therapy after radical prostatectomy by Agrawal, Shree, Efstathiou, Jason A., Michalski, Jeff M., Pisansky, Thomas Michael, Koontz, Bridget F., Liauw, Stanley L., Abramowitz, Matthew, Pollack, Alan, Anscher, Mitchell Steven, Moghanaki, Drew, Den, Robert B., Zietman, Anthony L., Lee, W. Robert, Stephans, Kevin L., Hearn, Jason W.D., Spratt, Daniel Eidelberg, Gao, Tianming, Kattan, Michael W., Stephenson, Andrew J., Tendulkar, Rahul D.

“…Abstract only 9 Background: Early salvage radiation therapy (SRT) following radical prostatectomy (RP) has been shown to reduce biochemical recurrence and…”
Get full text

Image guidance for post-prostatectomy radiotherapy: Are we missing the mark? by Kalman, Noah S., Banez, Lionel L., Gerber, Leah, Moul, Judd W., Anscher, Mitchell Steven, Lee, W. Robert, Koontz, Bridget F.

“…Abstract only 56 Background: Image-guided radiation therapy (IGRT) has been widely adopted for both definitive and post-operative prostate radiotherapy. In the…”
Get full text

The availability of and satisfaction with palliative care services among VHA-based radiation oncologists by Dawson, George A., Cheuk, Alice V., Jolly, Shruti, Gutt, Ruchika, Moghanaki, Drew, Fosmire, Helen, Lutz, Stephen T., Hagan, Michael Philip, Anscher, Mitchell Steven, Hoffman-Hogg, Lori, Kelly, Maria D.

“…Abstract only 55 Background: Palliative care services enhance quality of life in patients with advanced malignancies and are an integral component of…”
Get full text

Advanced radiation oncology technology within the Veterans Health Administration (VHA) by Dawson, George A., Cheuk, Alice V., Jolly, Shruti, Gutt, Ruchika, Fosmire, Helen, Lutz, Stephen T., Anscher, Mitchell Steven, Hagan, Michael Philip, Moghanaki, Drew, Hoffman-Hogg, Lori, Kelly, Maria D.

“…Abstract only 52 Background: The rapid evolution of technology in the treatment of cancer has paralleled other technological advancements in modern society…”
Get full text